Characteristics of Interim Publications of Randomized Clinical Trials and Comparison With Final Publications

Overview

Journal JAMA

Publisher American Medical Association

Specialty General Medicine

Date 2018 Jan 25

PMID 29362786

Citations 7

Authors

Steven Woloshin

Lisa M Schwartz

Pamela J Bagley

Heather B Blunt

Brian White

Affiliations

Soon will be listed here.

Citing Articles

Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: A randomized control trial.

Pashchenko O, Bromberg D, Dumchev K, LaMonaca K, Pykalo I, Filippovych M PLOS Glob Public Health. 2023; 2(11):e0000344.

PMID: 36962514 PMC: 10021202. DOI: 10.1371/journal.pgph.0000344.

Ethics in Psychiatric Research.

Grover S, Sarkar S, Sahoo S Indian J Psychiatry. 2022; 64(Suppl 1):S68-S80.

PMID: 35599654 PMC: 9122140. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_49_21.

Interim versus final results of the trial-not the flip side of the same coin!.

Yadava O Indian J Thorac Cardiovasc Surg. 2020; 34(3):333-334.

PMID: 33060889 PMC: 7525621. DOI: 10.1007/s12055-018-0682-7.

Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis.

Naci H, Davis C, Savovic J, Higgins J, Sterne J, Gyawali B BMJ. 2019; 366:l5221.

PMID: 31533922 PMC: 6749182. DOI: 10.1136/bmj.l5221.

Clinical trial publications.

Cuschieri S Saudi J Anaesth. 2019; 13(Suppl 1):S42-S43.

PMID: 30930719 PMC: 6398296. DOI: 10.4103/sja.SJA_575_18.

References

Petzer A, Fong D, Lion T, Dyagil I, Masliak Z, Bogdanovic A . High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trial. Haematologica. 2012; 97(10):1562-9. PMC: 3487557. DOI: 10.3324/haematol.2011.060087. View

Wang H, Rosner G, Goodman S . Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research. Clin Trials. 2016; 13(6):621-631. PMC: 5133138. DOI: 10.1177/1740774516649595. View

Bassler D, Briel M, Montori V, Lane M, Glasziou P, Zhou Q . Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 2010; 303(12):1180-7. DOI: 10.1001/jama.2010.310. View

Petzer A, Wolf D, Fong D, Lion T, Dyagil I, Masliak Z . High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study. Haematologica. 2010; 95(6):908-13. PMC: 2878787. DOI: 10.3324/haematol.2009.013979. View

Counsell N, Biri D, Fraczek J, Hackshaw A . Publishing interim results of randomised clinical trials in peer-reviewed journals. Clin Trials. 2016; 14(1):67-77. DOI: 10.1177/1740774516664689. View